EUCTR2005-001499-10-ES进行中（未招募）不适用
'Pilot trial of Pegilated Liposomal Doxorrubicin (Caelyx) in combination with Docetaxel (Taxotere) in advanced breast cancer patients'Estudio Piloto de Doxorrubicina Liposomal Pegilada (Caelyx) en combinación con Docetaxel (Taxotere) en pacientes con cáncer de mama avanzado
Dr. José Ramón Mel Lorenzo0 个研究点开始时间: 2006年4月28日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Female
入选标准
- •Aged > 18 years
- •Histologic diagnostic of breast cancer
- •Performance status of Karnofsky > 60%
- •Left ventricular ejecction > 50%
- •Hepatic and medular funtions adecuated
- •Mensurable lesions of metastatic breast cancer
- •No previous chemotherapy treatments for metastasic disease
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •No cardiopathy history
- •No hipersensibility for antraciclines therapy
- •No treatment failure to antraciclines therapy in previous 12 months
研究者
相似试验
招募中
2 期
A Phase II Trial of Liposomal Doxorubicin (PLD, DOXILTM) as 3rd Line Treatment in Relapsed, Plutinum - resistant Ovarian CancerOvarian CancerJPRN-UMIN000002814Osaka University Faculty of Medicine Department of obstetrics and gynecology43
已完成
2 期
A Phase II Trial of Liposomal Doxorubicin (PLD) + Carboplatin (CBDCA) as Treatment in Relapsed, Plutinum-sensitive Ovarian CancerOvarian cancerJPRN-UMIN000003944Osaka University Graduate School of Medicine Department of Obstetrics and Gynecology85
已完成
2 期
Pilot Study of Liposomal Doxorubicin Combined With Bevacizumab Followed by Bevacizumab Monotherapy in Adults With Advanced Kaposi s SarcomaSarcoma, KaposiNCT00923936National Cancer Institute (NCI)16
已完成
不适用
Phase I Trail of pegylated liposomal doxorubicin (PLD) in combination with Irinotecan (CPT-11) in Patients with Platinum Refractory and Resistant Ovarian cancerPatients with platinum-refractory and resistant ovarian cancerJPRN-UMIN000005525Fukuoka University, School of Medicine6
招募中
1 期
Phase I study of pegylated liposomal doxorubicin and cisplatin combination chemotherapy in patients with recurrent and refractory epithelial ovarian cancer.epithelial ovarian cancer, primary fallopian tube cancer, primary peritoneal cancerJPRN-UMIN000005798Cancer Institute Hospital18